CDMD Representatives Attends High-Level Dialogue on Cross-Border Cooperation in the Life and Health Industry in Changping, Beijing

2023-09-05 | Beijing, Shanghai

On 5th September, Mr. Liu Ning, the Vice Chair of Consumable and Disposable Medical Device Advisory Committee (CDMD), attended the high-level Dialogue of Healthy China-2023 Life and Health Industry Cross-border Cooperation "Changping-Fortune 500 Dialogue" on behalf of the European Chamber of Commerce. Mr. Liu Ning introduced the mission of the European Chamber of Commerce and the Healthcare Equipment Working Group. He mentioned that Changping District in Beijing has created a favourable business environment and a sound system of encouraging policies for foreign companies in the field of life sciences. The Chamber sees broad development space in Changping District, which has increased member companies' confidence and determination to develop their businesses in Changping. Many member companies of the Chamber have their own research and development centres and open innovation platforms, which have effectively promoted the construction of local innovation ecology. These open innovation platforms have many positive effects, such as introducing small and medium-sized enterprises with disruptive innovation and cutting-edge technology from around the world into the domestic market; attracting a large number of leading medical innovation talents from around the world to return; attracting a large amount of capital investment; forming industrial agglomeration; and promoting the all-round development of upstream and downstream research and development industries. After successful incubation, enterprises can gradually grow and become the main force of innovation, thus playing a driving and leading role in the industry. In summary, open innovation platforms have a very significant influence and spillover effect in the entire medical innovation field. The Chamber sees that Changping District is striving to build a local innovation ecosystem and encourage the construction of open innovation and research and development centres. The Chamber is also pleased to see that some domestic companies are developing in Changping. Furthermore, the Chamber hopes that open innovation can be more diversified and multi-level in the future. Member companies of the Chamber of Commerce have several advantages in the field of open innovation: they not only provide shared space but also have the world's most advanced experimental equipment. Most importantly, they can provide comprehensive support as multinational companies, including experts, R&D personnel, legal affairs, and funds. Global innovation enterprises and investors see the brand effect of multinational companies and will come in droves, forming a driving effect. The Chamber hopes that Changping District can have more opportunities for communication and cooperation with the European Chamber of Commerce in the field of open innovation, and we believe that it will definitely form an industrial agglomeration effect in the future.

CDMD Vice Chair Mr. Liu Ning presents at the High-Level Dialogue of Healthy China-2023 Life and Health Industry Cross-border Cooperation "Changping-Fortune 500 Dialogue" on behalf of the European Chamber of Commerce. The event took place on September 5th and served as a platform for cross-border cooperation in the life and health industry. Mr. Liu Ning introduced the mission of the European Chamber of Commerce and the Healthcare Equipment Working Group, highlighting the favorable business environment and sound policies for foreign companies in the field of life sciences in Changping District in Beijing.

The presentation emphasized the broad development space in the district, which has increased member companies' confidence and determination to develop their businesses in Changping. The open innovation platforms and research and development centers in the district have effectively promoted the construction of local innovation ecology, attracting small and medium-sized enterprises with disruptive innovation and cutting-edge technology from around the world into the domestic market, attracting a large number of leading medical innovation talents from around the world to return, and forming industrial agglomeration.

The presentation also highlighted the significant influence and spillover effect of open innovation platforms in the entire medical innovation field. The European Chamber of Commerce sees that Changping District is striving to build a local innovation ecosystem and encourage the construction of open innovation and research and development centers. The Chamber is also pleased to see that some domestic companies are developing in Changping. Furthermore, the Chamber hopes that open innovation can be more diversified and multi-level in the future.

Member companies of the Chamber of Commerce have several advantages in the field of open innovation, including providing shared space, having the world's most advanced experimental equipment, and being able to provide comprehensive support as multinational companies, including experts, R&D personnel, legal affairs, and funds. Global innovation enterprises and investors see the brand effect of multinational companies and will come in droves, forming a driving effect. The Chamber hopes that Changping District can have more opportunities for communication and cooperation with the European Chamber of Commerce in the field of open innovation, and we believe that it will definitely form an industrial agglomeration effect in the future.

Overall, the presentation served as an opportunity for CDMD to engage with industry leaders and promote cross-border cooperation in the life and health industry.